<DOC>
	<DOC>NCT02604992</DOC>
	<brief_summary>The primary objective of this study is to evaluate the comparative bioavailability of a test product of dronabinol oral solution administered under fed conditions to the reference listed drug (RLD) administered to participants under fed and fasted conditions. The secondary objective is to compare the onset of detectable dronabinol concentrations between dronabinol oral solution and the RLD.</brief_summary>
	<brief_title>Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Meets protocolspecified criteria for qualification Fully comprehends and signs the informed consent form, understands all study procedures, and can communicate satisfactorily with the Investigator and study coordinator History or current use of overthecounter medications, dietary supplements, or drugs outside protocolspecified parameters Signs, symptoms or history of any condition that, per protocol or in the opinion of the investigator, might compromise: 1. the safety or wellbeing of the participant or study staff 2. the safety or wellbeing of the participant's offspring (such as through pregnancy or breastfeeding) 3. the analysis of results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Comparative Bioavailability</keyword>
</DOC>